TANYA KOZUCH: Open Payments
NPI 1053169367 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $933 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| TOLMAR, INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Procept Biorobotics Corporation | 1 | $19 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $18 |
| UROGEN PHARMA, INC. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: Xtandi, Nubeqa, JATENZO, LYNPARZA, ERLEADA, GEMTESA, AQUABEAM ROBOTIC SYSTEM, PYLARIFY.
Industry payments across PA — which companies pay providers there.
